B. Mayer et al., 1993-01-26: Shows methylene blue directly inhibits purified nitric oxide synthase at low micromolar concentrations, making it a far poorer and less specific guanylate cyclase inhibitor than it had been assumed to be.
formation of L-citrulline by purified NO synthase was completely inhibited by 30 microM methylene blue (IC50 = 5.3 and 9.2 microM in the absence and presence of SOD, respectively)
Abstract
B. Mayer et al., 1993-01-26: Shows methylene blue directly inhibits purified nitric oxide synthase at low micromolar concentrations, making it a far poorer and less specific guanylate cyclase inhibitor than it had been assumed to be. Laboratory study: purified NO synthase, cultured endothelial cells, isolated blood vessels. Country: Austria (University of Graz). Concentrations: IC50 5.3 microM (without SOD) and 9.2 microM (with SOD) for NOS; about 60 microM for 50% inhibition of stimulated guanylyl cyclase, maximal 72% at 1 mM. Route: in vitro. Funder: 'Research Support, Non-U.S. Gov't' (Austrian science fund; see paper). Conflicts: none declared. Comparator: untreated enzyme/vessels; SOD added to control for superoxide. Bearing note: this simultaneously supports 'MB affects NOS and guanylate cyclase' and corrects the widespread statement that MB is a selective guanylate cyclase inhibitor – the authors say the opposite. Also filed as MTC-048 (claims C4, C8). Study type: lab.
